250 related articles for article (PubMed ID: 31019620)
1. Thrombocytosis as a Rare Paraneoplastic Syndrome Occurring in Hepatocellular Carcinoma: A Case Report.
Abbas H; Hanif S; Tariq H; Chilimuri S
Gastroenterology Res; 2019 Apr; 12(2):96-99. PubMed ID: 31019620
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Hwang SJ; Luo JC; Li CP; Chu CW; Wu JC; Lai CR; Chiang JH; Chau GY; Lui WY; Lee CC; Chang FY; Lee SD
World J Gastroenterol; 2004 Sep; 10(17):2472-7. PubMed ID: 15300887
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients.
Ülger Y; Delik A
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):769-773. PubMed ID: 34974464
[TBL] [Abstract][Full Text] [Related]
4. [The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].
Huh UY; Kim JH; Kim BH; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Korean J Hepatol; 2005 Sep; 11(3):275-83. PubMed ID: 16177554
[TBL] [Abstract][Full Text] [Related]
5. [A case of hepatocellular carcinoma with paraneoplastic hypercholesterolemia, thrombocytosis and hypoglycemia].
Inomata E; Sohda T; Nakane H; Morihara D; Hirose O; Kitamura Y; Iwata K; Irie M; Takeyama Y; Watanabe H; Sakisaka S
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1231-5. PubMed ID: 17675826
[TBL] [Abstract][Full Text] [Related]
6.
Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R
J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma Without Cirrhosis Presenting With Hypercalcemia: Case Report and Literature Review.
Newman NB; Jabbour SK; Hon JD; Berman JJ; Malik D; Carpizo D; Moss RA
J Clin Exp Hepatol; 2015 Jun; 5(2):163-6. PubMed ID: 26155045
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.
Luo JC; Hwang SJ; Wu JC; Li CP; Hsiao LT; Lai CR; Chiang JH; Lui WY; Chang FY; Lee SD
Cancer; 1999 Sep; 86(5):799-804. PubMed ID: 10463978
[TBL] [Abstract][Full Text] [Related]
9. Case report: Hepatic tuberculosis mimicking hepatocellular carcinoma in a patient with cirrhosis induced by hepatitis B virus.
Hu N; Wu Y; Tang M; Luo T; Yuan S; Li C; Lei P
Front Med (Lausanne); 2022; 9():1005680. PubMed ID: 36457572
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic Hypercholesterolemia Identified in an Adult Male Diagnosed With Metastatic Yolk Sac Tumor.
Agudile EP; Khan M; Tan PE; Kozyreva O
Cureus; 2023 Aug; 15(8):e44442. PubMed ID: 37791221
[TBL] [Abstract][Full Text] [Related]
11. Secondary Polycythemia and Non-Islet Cell Tumor-induced Hypoglycemia in Advanced Hepatocellular Carcinoma: A Case Report.
Paramitha MS; Esa DF; Hustrini NM; Mulansari NA; Hasan I; Harahap AS
Acta Med Indones; 2024 Jan; 56(1):93-101. PubMed ID: 38561874
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.
Burciu C; Sirli R; Bende R; Vuletici D; Miutescu B; Moga T; Bende F; Popescu A; Sporea I; Koppandi O; Miutescu E; Iovanescu D; Danila M
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674198
[No Abstract] [Full Text] [Related]
13. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma.
Qu Q; Wang S; Chen S; Zhou L; Rui JA
Am Surg; 2014 Feb; 80(2):191-6. PubMed ID: 24480222
[TBL] [Abstract][Full Text] [Related]
15. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin-producing hepatocellular carcinoma.
Ryu T; Nishimura S; Miura H; Yamada H; Morita H; Miyazaki H; Kitamura S; Miura Y; Saito T
Intern Med; 2003 Aug; 42(8):730-4. PubMed ID: 12924502
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of basic research in hepatocellular carcinoma.
Dhanasekaran R; Venkatesh SK; Torbenson MS; Roberts LR
J Hepatol; 2016 Mar; 64(3):736-45. PubMed ID: 26450813
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
[TBL] [Abstract][Full Text] [Related]
20. Portal vein thrombosis.
Chawla YK; Bodh V
J Clin Exp Hepatol; 2015 Mar; 5(1):22-40. PubMed ID: 25941431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
